Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine and postoperative cognitive function in elderly patients undergoing robot-assisted radical prostatectomy
KCT0003080Phase 4Not yet recruiting
- Sponsor
- Eulji University
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dexmedetomidine in prostate cancer (PCa), sponsored by Eulji University. Planned start Aug 2018; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on KCT0003080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0003080.